FDA Brief

Warning letters Drugs

FDA warning letter to

Rxgoodusa

High riskIssued Apr 1Posted Apr 14Center for Drug Evaluation and Research (CDER)

FDA warned Rxgoodusa that its website sells unapproved, misbranded opioid and benzodiazepine drugs to U.S. consumers without prescriptions.

What happened

FDA reviewed www.rxgoodusa.com and found it offering tramadol and diazepam products for sale to U.S. consumers with claims that they treat pain, seizures, anxiety, and other conditions. FDA said the drugs are unapproved new drugs and misbranded, and it noted a prior August 1, 2025 warning letter to the same operation under www.usaquickmeds.com for similar violations.

What FDA found

  1. The website offers unapproved new drugs, including tramadol and diazepam, without FDA-approved applications.

    FD&C Act sections 301(d) and 505(a) [21 U.S.C. §§ 331(d), 355(a)]
  2. The drugs' labeling lacks adequate directions for safe use by a layperson, so they are misbranded.

    FD&C Act section 502(f)(1) [21 U.S.C. § 352(f)(1)]
  3. The website offers prescription drugs without requiring a prescription, which misbrands them.

    FD&C Act sections 503(b)(1) and 301(k) [21 U.S.C. §§ 353(b)(1), 331(k)]
  4. FDA said similar violations continued after an August 1, 2025 warning letter.

What FDA wants

FDA tells Rxgoodusa to stop offering any unapproved and misbranded drugs to U.S. consumers and to respond in writing within 15 working days describing corrective steps and how it will prevent recurrence.

Who should pay attention

  • online pharmacies and websites selling prescription drugs
  • platforms and payment processors that host or process sales for such sites
  • consumers and clinicians dealing with opioid or benzodiazepine risks

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk
  4. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk